Shamanism or Shamanisms, a comparative approach toward Siberian Shamanism
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Shamanism has been considered as a singular phenomenon in most of the studies carried out about Shamanism so far, and it has not been taken into consideration that there are different types of Shamanism. Shamanist beliefs, which were developed in a very large region such as Siberia, were divided into different branches as a result of different social, cultural and political effects in Siberia, and led to the emergence of Shamanist practices called Paleo-Siberian Shamanism and Neo-Siberian Shamanism. The thesis will examine Siberian Shamanism in a comparative way, starting from the concepts of Paleo Siberia and Neo Siberia, and will reveal the necessity of mentioning Shamanism as plural rather than singular. Considering the fact that Siberia is a very wide geographical region, the subject of the study will be limited to three Paleo Siberian and three Neo Siberian groups. Keywords: Siberia, Paleo Siberia, Neo Siberia, Shamanism
Author
Cemil Ömer Kızılhan
How to Cite
Cemil Ömer Kızılhan (Master Thesis). Shamanism or Shamanisms, a comparative approach toward Siberian Shamanism, 2023, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)